Report : Europe Anti-Viral Therapies Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type (Generic Drugs and Branded Drugs), Mechanism of Action (Nucleotide Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, and Others), and Application (HIV, Hepatitis, Virus Influenza, Herpes, and Other Applications), and Country
Branded Drugs Segment Accounted for Larger Share of Anti-Viral Therapies Market in 2019
According to our new market research study on “Europe Anti-Viral Therapies Market Forecast to 2027 – Regional Analysis and Forecast – by Type, Mechanism of Action, and Application,” the market is expected to reach US$ 21,122.66 million by 2027 from US$11,401.67 million in 2019; it is estimated to grow at a CAGR of 8.1% from 2020 to 2027. The report provides trends prevailing in the Europe anti-viral therapies market, and drivers and hindrances pertaining to the market growth.
In 2019, the branded drugs segment accounted for a larger share of the Europe antiviral therapies market. The branded antiviral drugs are more trusted than the generic drugs. Further, robust research and development activities, increasing number of drug discoveries, and rising number of patents for drugs are the factors supporting the growth of this segment.
The growth of the Europe anti-viral therapies market is mainly attributed to the growing prevalence of viral diseases, increasing R&D expenditures of pharmaceutical companies, and strong pipeline of anti-viral agent launch. Additionally, the availability of advanced therapeutic platforms for viral diseases and awareness programs to eradicate viral diseases are further projected to drive the market in this region during the forecast period. However, the high cost of drug development is a key factor hindering the market growth.
GlaxoSmithKline plc; AbbVie Inc.; AstraZeneca; Johnson and Johnson Services, Inc; and F. HOFFMANN-LA ROCHE LTD are among the leading companies operating in the Europe anti-viral therapies market.
Europe Anti-Viral Therapies Market, by Country, 2019 (%)
The Report Segments Europe Anti-Viral Therapies Market as Follows:
Europe Anti-Viral Therapies Market– by Type
- Branded Drugs
- Generic Drugs
Europe Anti-Viral Therapies Market – by Mechanism of Action
- Nucleotide Polymerase Inhibitors
- Reverse Transcriptase Inhibitors
- Protease Inhibitors
- Others
Europe Anti-Viral Therapies Market – by Application
- HIV
- Hepatitis
- Virus Influenza
- Herpes
- Others
Europe Anti-Viral Therapies Market – by Country
- Germany
- UK
- France
- Italy
- Spain
Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com